The worldwide increase in antibiotic resistance in bacteria is a challenge for effectively treating infectious diseases. Because of the indispensable nature of antibiotics in the modern medical world, the management of antibiotic resistance is an important consideration in the treatment and cure of individual patients. Yanfang Feng conducts research into the evolution of resistance against clinically relevant antibiotics. She hereby uses the bacteria 'pseudomonas aeruginosa' as a model organism. Her ultimate aim is to devise an optimal treatment strategy in which successful treatment is combined with minimal development of antibiotic resistance.
Y. Feng, Optimization of Treatment Protocols to Prevent de Novo Development of Antibiotic Resistance in Pseudomonas Aeruginosa.
Prof. S. Brul
Prof. B.H. ter Kuile
Dr C. Schultsz
This event is open to the public.